Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.
Gavoille A, Leray E, Marignier R, Rollot F, Casey R, Mathey G, Michel L, De Seze J, Ciron J, Ruet A, Maillart E, Labauge P, Zephir H, Laplaud DA, Papeix C, Defer G, Moreau T, Berger E, Dubessy AL, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al Khedr A, Casez O, Bourre B, Wahab A, Magy L, Camdessanche JP, Doghri I, Moulin S, Labeyrie C, Hankiewicz K, Dos Santos A, Pottier C, Manchon E, Tchikviladze M, Lebrun-Frenay C, Vukusic S; OFSEP investigators.
Gavoille A, et al. Among authors: leray e.
Neurology. 2025 Aug 26;105(4):e213907. doi: 10.1212/WNL.0000000000213907. Epub 2025 Jul 30.
Neurology. 2025.
PMID: 40737571